ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 165 filers reported holding ENDOLOGIX INC in Q2 2016. The put-call ratio across all filers is 104.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,338,000 | +27.7% | 250,000 | +6.4% | 0.11% | +14.6% |
| Q3 2017 | $1,048,000 | +334.9% | 235,000 | +604.8% | 0.10% | +300.0% |
| Q1 2017 | $241,000 | -48.8% | 33,341 | -59.5% | 0.02% | -60.7% |
| Q4 2016 | $471,000 | +265.1% | 82,350 | +696.4% | 0.06% | +110.3% |
| Q2 2016 | $129,000 | – | 10,340 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 1,165,428 | $35,549,000 | 17.87% |
| Iguana Healthcare Management, LLC | 160,000 | $2,790,000 | 1.59% |
| Elk Creek Partners, LLC | 112,839 | $1,968,000 | 1.42% |
| Tygh Capital Management, Inc. | 338,424 | $5,902,000 | 1.24% |
| NEXT CENTURY GROWTH INVESTORS LLC | 2,471,336 | $43,100,000 | 1.19% |
| First Light Asset Management, LLC | 75,738 | $1,321,000 | 1.12% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 273,954 | $4,778,000 | 1.07% |
| WASHINGTON CAPITAL MANAGEMENT, INC | 195,316 | $3,406,000 | 0.82% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,605,163 | $27,994,000 | 0.73% |
| ArrowMark Colorado Holdings LLC | 1,286,044 | $22,429,000 | 0.70% |